Related Experiment Videos
G protein activation by endomorphins in the mouse periaqueductal gray matter
M Narita1, H Mizoguchi, M Narita
1Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisc. 53226, USA.
Abstract:
The midbrain periaqueductal gray matter (PAG) is an important brain region for the coordination of mu-opioid-induced pharmacological actions. The present study was designed to determine whether newly isolated mu-opioid peptide endomorphins can activate G proteins through mu-opioid receptors in the PAG by monitoring the binding to membranes of the non-hydrolyzable analog of GTP, guanosine-5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS). An autoradiographic [(35)S]GTPgammaS binding study showed that both endomorphin-1 and -2 produced similar anatomical distributions of activated G proteins in the mouse midbrain region. In the mouse PAG, endomorphin-1 and -2 at concentrations from 0.001 to 10 microM increased [(35)S]GTPgammaS binding in a concentration-dependent manner and reached a maximal stimulation of 74.6+/-3.8 and 72.3+/-4.0%, respectively, at 10 microM. In contrast, the synthetic selective mu-opioid receptor agonist [D-Ala(2),NHPhe(4), Gly-ol]enkephalin (DAMGO) had a much greater efficacy and produced a 112.6+/-5.1% increase of the maximal stimulation. The receptor specificity of endomorphin-stimulated [(35)S]GTPgammaS binding was verified by coincubating membranes with endomorphins in the presence of specific mu-, delta- or kappa-opioid receptor antagonists. Coincubation with selective mu-opioid receptor antagonists beta-funaltrexamine or D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Phe-Thr-NH(2) (CTOP) blocked both endomorphin-1 and-2-stimulated [(35)S]GTPgammaS binding. In contrast, neither delta- nor kappa-opioid receptor antagonist had any effect on the [(35)S]GTPgammaS binding stimulated by either endomorphin-1 or -2. These findings indicate that both endomorphin-1 and -2 increase [(35)S]GTPgammaS binding by selectively stimulating mu-opioid receptors with intrinsic activity less than that of DAMGO and suggest that these new endogenous ligands might be partial agonists for mu-opioid receptors in the mouse PAG.
Insights
Newly discovered endomorphins activate G proteins via mu-opioid receptors in the periaqueductal gray matter (PAG). These endogenous peptides act as partial agonists, showing less efficacy than DAMGO in stimulating G protein activity.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- The midbrain periaqueductal gray matter (PAG) is crucial for coordinating mu-opioid actions.
- Endomorphins are newly identified endogenous mu-opioid peptides.
Purpose of the Study:
- To investigate if endomorphins activate G proteins through mu-opioid receptors in the PAG.
- To characterize the efficacy and receptor specificity of endomorphins in the PAG.
Main Methods:
- Autoradiographic [(35)S]GTPgammaS binding assay was used to monitor G protein activation.
- Concentration-dependent binding studies were performed with endomorphin-1, endomorphin-2, and DAMGO.
- Receptor specificity was assessed using selective mu-, delta-, and kappa-opioid receptor antagonists.
Main Results:
- Endomorphin-1 and -2 dose-dependently increased [(35)S]GTPgammaS binding in the mouse PAG.
- Both endomorphins exhibited maximal stimulation of 72-75%, significantly lower than DAMGO (112%).
- Mu-opioid receptor antagonists blocked endomorphin-induced binding, while delta- and kappa-antagonists had no effect.
Conclusions:
- Endomorphin-1 and -2 selectively activate mu-opioid receptors in the mouse PAG.
- These peptides function as partial agonists, with lower intrinsic activity compared to DAMGO.
- Findings suggest endomorphins are endogenous ligands that modulate PAG function via partial mu-opioid agonism.